药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603259 药明康德

已收盘 07-30 15:00:00

{"stockData":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":98.85,"timestamp":1753858800000,"preClose":98.69,"halted":0,"volume":92913994,"delay":0,"changeRate":0.0016,"floatShares":2485000000,"shares":2872000000,"eps":4.7947,"marketStatus":"已收盘","change":0.16,"latestTime":"07-30 15:00:00","open":98.6,"high":102.49,"low":97.25,"amount":9296000000,"amplitude":0.0531,"askPrice":98.86,"askSize":32,"bidPrice":98.85,"bidSize":133,"shortable":0,"etf":0,"ttmEps":4.7947,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753925400000},"marketStatusCode":5,"adr":0,"adjPreClose":98.69,"symbolType":"stock","openAndCloseTimeList":[[1753839000000,1753846200000],[1753851600000,1753858800000]],"highLimit":108.56,"lowLimit":88.82,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2872217205,"isCdr":false,"pbRate":4.74,"roa":"--","peRate":20.616514,"roe":"13.93%","epsLYR":3.28,"committee":0.765014,"marketValue":283919000000,"turnoverRate":0.0374,"status":0,"hkstockBrief":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":112,"timestamp":1753862890006,"preClose":111.7,"halted":0,"volume":19358565,"delay":0,"premium":"+4.12"},"floatMarketCap":245656000000},"requestUrl":"/m/hq/s/603259","defaultTab":"news","newsList":[{"id":"2555041246","title":"重磅利好！百亿市值CXO个股梳理","url":"https://stock-news.laohu8.com/highlight/detail?id=2555041246","media":"天天基金网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555041246?lang=zh_cn&edition=full","pubTime":"2025-07-30 19:28","pubTimestamp":1753874900,"startTime":"0","endTime":"0","summary":"拉长时间范围看，年内至今在市值超百亿的CXO个股中，昭衍新药涨幅超111%，位列第一，药明康德、皓元医药、凯莱英、博腾股份等个股涨幅在83%至60%之间，药石科技、九洲药业、康龙化成、泰格医药等个股涨幅也均超20%。同时药明康德上调全年销售预期。信达证券表示，创新药行情火热，大额BD出海授权交易频出，带动医药企业加码研发投入并加速研发项目推进速度，目前早期研发阶段需求修复已经初显成效，利好CXO等上游产业链。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730203937a6c9c124&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730203937a6c9c124&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1997245177.USD","688131","LU1979443071.USD","LU1997244956.HKD","LU2328871848.SGD","01276","02359","BK0216","LU1997245094.SGD","LU2495084118.USD","LU0456842615.SGD","LU2488822045.USD","LU1934453819.USD","03347","603259","600276","LU1969619763.USD"],"gpt_icon":0},{"id":"2555045529","title":"Morgan Stanley增持药明康德(02359)约192.96万股 每股作价约95.86港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555045529","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555045529?lang=zh_cn&edition=full","pubTime":"2025-07-30 18:57","pubTimestamp":1753873066,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月24日，Morgan Stanley增持药明康德(02359)192.9554万股，每股作价95.8573港元，总金额约为1.85亿港元。增持后最新持股数目约为2058.81万股，持股比例为5.31%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323734.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0267386448.USD","LU0098860793.USD","LU2023251221.USD","LU2133065610.SGD","LU2045819591.USD","BK4127","LU1989772923.USD","LU1046422090.SGD","LU2089283258.USD","LU0708995583.HKD","LU1979443071.USD","BK4504","BK1141","LU0234570918.USD","BK1583","LU0795875086.SGD","LU1997245094.SGD","LU1934453819.USD","MSPQL","LU0912757837.SGD","BK4534","LU1969619763.USD","BK4588","LU0106831901.USD","LU0006306889.USD","LU2271345857.HKD","MSPQV","LU2347655156.SGD","IE00BKVL7J92.USD","LU2028103732.USD","IE00BZ1G4Q59.USD","LU1074936037.SGD","LU1668664300.SGD","LU2111349929.HKD","LU1732799900.SGD","LU0320764599.SGD","LU0795875169.SGD","LU1989772840.SGD","LU1997244956.HKD","LU0971096721.USD","LU1363072403.SGD","LU0106261372.USD","LU1548497426.USD","LU1997245177.USD","02359","BK1576","603259","LU0158827781.USD","LU2357305700.SGD","LU1720051108.HKD"],"gpt_icon":0},{"id":"2555014170","title":"药明康德寻求配售约6.5亿美元资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2555014170","media":"36氪","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555014170?lang=zh_cn&edition=full","pubTime":"2025-07-30 17:25","pubTimestamp":1753867513,"startTime":"0","endTime":"0","summary":"药明康德寻求配售约6.5亿美元资金，发行价格区间为每股104.16-106.40港元。（新浪财经）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730172833a46b5250&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730172833a46b5250&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","LU1997244956.HKD","LU2488822045.USD","LU1934453819.USD","BK0216","LU2495084118.USD","LU1997245177.USD","LU0456842615.SGD","LU1969619763.USD","603259","LU1979443071.USD","LU1997245094.SGD"],"gpt_icon":0},{"id":"2555014592","title":"7月30日药明康德现790.8万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2555014592","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555014592?lang=zh_cn&edition=full","pubTime":"2025-07-30 17:20","pubTimestamp":1753867231,"startTime":"0","endTime":"0","summary":"证券之星消息，7月30日药明康德发生大宗交易，交易数据如下：大宗交易成交价格98.85元，成交8万股，成交金额790.8万元，买方营业部为华泰证券股份有限公司北京雍和宫证券营业部，卖方营业部为国泰海通证券股份有限公司总部。近三个月该股共发生11笔大宗交易，合计成交1.42万手，折价成交3笔，溢价成交5笔。截至2025年7月30日收盘，药明康德报收于98.85元，上涨0.16%，换手率3.74%，成交量92.91万手，成交额92.96亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073000027976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1997245094.SGD","LU2125910500.SGD","LU1979443071.USD","LU1997245177.USD","LU1969619763.USD","LU1046422090.SGD","LU1934453819.USD","LU2328871848.SGD","LU2242644610.SGD","LU2488822045.USD","02359","BK0216","BK1583","LU0052750758.USD","BK1576","LU1997244956.HKD","LU0320764599.SGD","LU2495084118.USD","603259","LU2045819591.USD","LU0708995583.HKD","BK1141","LU0456842615.SGD"],"gpt_icon":0},{"id":"2555049856","title":"公募再加仓医药！恒瑞、药明康德、信达、三生获重仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2555049856","media":"医药魔方Invest","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555049856?lang=zh_cn&edition=full","pubTime":"2025-07-30 17:14","pubTimestamp":1753866873,"startTime":"0","endTime":"0","summary":"其中，恒瑞医药、药明康德、信达生物、迈瑞医疗位列公募基金持仓总市值前五。相较于Q1，恒瑞医药和药明康德依旧稳坐公募基金数量前二，新面孔则是信达生物和三生制药。6月份，信达生物的玛仕度肽注射液正式获批上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730195538a6c9afd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730195538a6c9afd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","LU0456842615.SGD","688068","LU1979443071.USD","LU1934453819.USD","LU1997244956.HKD","01276","688266","BK0183","LU1655091616.SGD","BK0216","BK0239","LU0405327148.USD","LU1997245177.USD","LU1997245094.SGD","03347","688235","LU2580892862.HKD","LU1328615791.USD","600276","LU2495084118.USD","BK0028","159938","01801","688382","BK0012","LU2148510915.USD","LU1969619763.USD","BK0188","BK0196","LU2580892789.USD","LU1064131003.USD","LU2328871848.SGD","LU0405327494.USD","LU2488822045.USD","02359","603259","LU1064130708.USD"],"gpt_icon":0},{"id":"2555501547","title":"花旗：升药明康德(02359)目标价至130港元 评级“买入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2555501547","media":"智通财经","labels":["rating"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555501547?lang=zh_cn&edition=full","pubTime":"2025-07-30 15:54","pubTimestamp":1753862091,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，花旗发布研报称，基于化学业务推动的毛利率扩张、行政管理费用率下降，以及更高的投资收益，将药明康德2025年至2027年每股盈利预测分别上调3%、6%及7%。因此，鉴于更乐观的盈利前景，将H股目标价从95港元上调至130港元;药明康德A股目标价从88元人民币上调至119元人民币。药明康德为该行在合同研发生产组织领域的首选股，评级“买入”。药明康德管理层上调2025年指引，主要是由于产能快速扩张，而非关税战前的订单激增。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323585.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","603259"],"gpt_icon":1},{"id":"2555018809","title":"镁伽科技冲刺IPO！高盛、中金、药明康德押注的百亿龙头，3年巨亏22亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2555018809","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555018809?lang=zh_cn&edition=full","pubTime":"2025-07-30 14:54","pubTimestamp":1753858465,"startTime":"0","endTime":"0","summary":"镁伽科技称2023年这部分的收入减少主要由于部分疫情相关产品的市场需求减少。造成连年亏损的主要原因之一便是高额的研发投入，报告期内，镁伽科技的研发成本分别为3.40亿元、3.08亿元和3.94亿元，分别占收入的74.8%、46.4%和42.4%。大额亏损使得镁伽科技的现金流状况同样不容乐观。除了现金流的压力，镁伽科技的债务状况也在持续恶化。或许这也是镁伽科技冲刺港股IPO的原因之一，通过上市融资，来缓解当下的燃眉之急。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730145914a46b0303&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730145914a46b0303&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1979443071.USD","LU1934453819.USD","LU0456842615.SGD","LU1997245177.USD","LU2328871848.SGD","02359","BK0216","603259","LU2495084118.USD","LU1997244956.HKD","LU1969619763.USD","LU1997245094.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2555099098","title":"中金：升药明康德(02359.HK)目标价至126港元 次季业绩胜预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2555099098","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555099098?lang=zh_cn&edition=full","pubTime":"2025-07-30 11:43","pubTimestamp":1753847007,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["603259","LU0052750758.USD","CNHmain","LU0320764599.SGD","CYB","02359","MUCmain","UCmain","LU2488822045.USD","LU0456842615.SGD","LU1934453819.USD","BK1141","LU2125910500.SGD","LU2045819591.USD","MCNHmain","LU1997245177.USD","LU2495084118.USD","LU2242644610.SGD","LU0708995583.HKD","LU1997245094.SGD","LU1979443071.USD","BK1576","LU2328871848.SGD","BK1583","LU1046422090.SGD","LU1969619763.USD","BK0216","LU1997244956.HKD"],"gpt_icon":0},{"id":"2555962600","title":"医药研发外包CRO，谁是盈利最强企业？","url":"https://stock-news.laohu8.com/highlight/detail?id=2555962600","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555962600?lang=zh_cn&edition=full","pubTime":"2025-07-30 10:59","pubTimestamp":1753844349,"startTime":"0","endTime":"0","summary":"CRO又称“医药研发外包企业”，是指通过合同形式为医药企业在药物研发过程中提供专业化外包服务的公司或机构。医药研发外包CRO产业链企业盈利能力企业盈利能力通常表现为一定时期内企业收益数额的多少及其水平的高低。本文为企业价值系列之篇，共选取48家医药研发外包CRO产业链企业作为研究样本，并以净资产收益率、毛利率、净利率等为评价指标。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073010591494c2dfe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073010591494c2dfe8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","688117","03759","603456","688131","688621","688073","BK0216","603259","02359"],"gpt_icon":0},{"id":"2555578095","title":"研报掘金｜中金：上调药明康德H股目标价至126港元 维持“跑赢行业”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2555578095","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555578095?lang=zh_cn&edition=full","pubTime":"2025-07-30 10:05","pubTimestamp":1753841120,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0052750758.USD","159982","BK0216","LU1997245094.SGD","LU2488822045.USD","LU1979443071.USD","LU1997245177.USD","LU0456842615.SGD","LU2125910500.SGD","02359","LU2242644610.SGD","LU1997244956.HKD","LU1969619763.USD","LU0708995583.HKD","399300","BK1583","LU1046422090.SGD","LU2045819591.USD","LU1934453819.USD","603259","LU2495084118.USD","BK1141","LU2328871848.SGD","LU0320764599.SGD","BK1576"],"gpt_icon":0},{"id":"2555357093","title":"精准医疗概念盘中拉升，药明康德涨1.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555357093","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555357093?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:38","pubTimestamp":1753839484,"startTime":"0","endTime":"0","summary":"07月30日，精准医疗概念盘中拉升，截至09点38分，精准医疗概念整体指数上涨0.64%，报1120.070点。从个股上来看，该概念的成分股中，药明康德涨1.92%，复星医药、仁度生物、丽珠集团涨幅居前。从资金上来看，截止发稿，精准医疗概念主力净流入为-8129.78万，其中复星医药受到资金热捧，主力净流入2523.16万；拉长时间线来看，该板块近20日主力资金净流入-45.04亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730093804a6c8ada4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730093804a6c8ada4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","603259","688193","LU1979443071.USD","LU2495084118.USD","LU0456842615.SGD","LU1934453819.USD","LU2328871848.SGD","LU1997245094.SGD","BK0239","02359","LU1969619763.USD","BK0216","LU1997245177.USD","LU1997244956.HKD"],"gpt_icon":0},{"id":"2555955590","title":"7月29日杠杆资金净买入前十：新易盛（11.40亿元）、寒武纪（7.80亿元）","url":"https://stock-news.laohu8.com/highlight/detail?id=2555955590","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555955590?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:09","pubTimestamp":1753837752,"startTime":"0","endTime":"0","summary":"沪深两市数据显示，7月29日，融资净买入前十的股票分别为：新易盛（11.40亿元）、寒武纪（7.80亿元）、药明康德（3.56亿元）、国泰海通（2.57亿元）、民生银行（2.41亿元）、伊利股份（2.19亿元）、华泰证券（2.02亿元）、上海电气（2.02亿元）、复星医药（1.99亿元）、华友钴业（1.95亿元）。本文源自：金融界作者：金股通","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730091328a6c8a198&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730091328a6c8a198&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02359","BK1564","BK1147","02196","603799","600887","601211","600196","06886","601688","02611","603259"],"gpt_icon":0},{"id":"2555098666","title":"花旗：予药明康德(02359.HK)“买入”评级 目标价95港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555098666","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555098666?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:07","pubTimestamp":1753837643,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["603259","LU0170899867.USD","LU2242644610.SGD","UCmain","LU1791807156.HKD","LU2495084118.USD","CNHmain","LU1997244956.HKD","LU2045819591.USD","LU0106831901.USD","LU0477156953.USD","ZTmain","LU2236285917.USD","LU1162221912.USD","BK0216","02359","ZFmain","LU1046422090.SGD","CYB","LU1366192091.USD","LU1244550577.SGD","LU2462157665.USD","LU0162691827.USD","UBmain","BK1141","MUCmain","IE00BSNM7G36.USD","LU0648001328.SGD","LU2125154778.USD","LU0052750758.USD","BK4207","BK4566","LU0128525689.USD","LU2417539215.USD","LU1244550494.USD","LU0320765646.SGD","ZBmain","MCNHmain","LU2488822045.USD","BK1576","TNmain","BK4534","ZNmain","LU2456880835.USD","LU2125910500.SGD","LU2360032135.SGD","LU2125154935.USD","LU0980610538.SGD","LU1997245177.USD","LU0052756011.USD"],"gpt_icon":0},{"id":"2555156060","title":"【券商聚焦】中泰国际上调药明康德(02359)评级至“买入” 同步升目标价23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555156060","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555156060?lang=zh_cn&edition=full","pubTime":"2025-07-30 08:35","pubTimestamp":1753835715,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中泰国际研报指，药明康德 上半年收入同比增加20.6%至208.0亿元，反映核心业务盈利的Non-IFRS经调整净利润同比增加44.4%至63.1亿元，股东净利润同比增加95.5%至82.9亿元。公司宣布将按照每10股派发3.50元人民币现金股息派发中期股息，首次派发中期股息，2025年股息率有望提升至35%以上，该机构认为将增强市场信心。根据调整后DCF模型，目标价从98.20港元上调至121.00港元。评级上调至“买入”。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1963105","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359","603259"],"gpt_icon":1},{"id":"2555057357","title":"药明康德业绩狂飙引爆CXO板块，新一轮景气周期来了吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2555057357","media":"澎湃新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555057357?lang=zh_cn&edition=full","pubTime":"2025-07-29 22:28","pubTimestamp":1753799280,"startTime":"0","endTime":"0","summary":"创新药板块周二全面爆发，CXO方向领涨。截至7月29日收盘，Wind创新药指数涨3.23%，WindCRO指数涨6.37%，CXO指数涨7.01%。其一，7月28日晚间，“CXO一哥”药明康德发布的2025年半年度报告显示，该公司上半年实现营收207.99亿元，同比增长20.64%；实现归属于上市公司股东的净利润85.61亿元，同比大幅增长101.92%。随着全球创新药研发持续活跃，以及国内政策支持和行业景气度逐步回升，CXO板块有望迎来全面复苏，科研上游行业景气度呈现明显回升趋势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072922330094c1bf1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072922330094c1bf1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1997245094.SGD","02359","LU1997245177.USD","LU0456842615.SGD","LU2488822045.USD","LU1934453819.USD","BK0216","LU2328871848.SGD","LU1969619763.USD","603259","LU1997244956.HKD","LU1979443071.USD","LU2495084118.USD"],"gpt_icon":0},{"id":"2555524290","title":"中证高端制造50指数报1492.82点，前十大权重包含北方华创等","url":"https://stock-news.laohu8.com/highlight/detail?id=2555524290","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555524290?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:19","pubTimestamp":1753795155,"startTime":"0","endTime":"0","summary":"数据统计显示，中证高端制造50指数近一个月上涨10.15%，近三个月上涨13.05%，年至今上涨6.21%。从中证高端制造50指数持仓样本的行业来看，工业占比37.06%、信息技术占比30.98%、医药卫生占比13.98%、可选消费占比12.66%、通信服务占比5.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921232894c1a17e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921232894c1a17e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00981","603259","LU2495084118.USD","SG9999001093.SGD","002371","161037","LU1997244956.HKD","688981","LU1820825898.SGD","LU1064131003.USD","LU2328871848.SGD","LU1064130708.USD","02359","LU2148510915.USD","BK0188","SGXZ49509284.SGD","LU1146622755.USD","BK0251","BK0028","BK0125","SG9999003461.SGD","LU1997245094.SGD","LU1969619763.USD","LU1328615791.USD","BK0214","SGXZ81163826.USD","LU1997245177.USD"],"gpt_icon":0},{"id":"2555056739","title":"7月29日16股被评买入评级！福能股份上涨空间超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555056739","media":"东方财富研究中心","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555056739?lang=zh_cn&edition=full","pubTime":"2025-07-29 19:46","pubTimestamp":1753789595,"startTime":"0","endTime":"0","summary":"东方财富Choice数据显示，截至7月29日19点，当天有16股被券商评为买入评级，包括东鹏饮料、药明康德、科沃斯、恒瑞医药、海大集团、苏泊尔等股票，其中海大集团、恒瑞医药被3家券商评为买入评级，东鹏饮料被2家券商评为买入评级。从部分个股券商给出的目标价来看，英科医疗、瑞纳智能、福能股份、濮耐股份上涨空间超30%。机构目标价涨幅前20以近一月券商研报为样本，按机构目标价（有多家券商给出目标价的，取最大值）和最新收盘价相比，截至7月29日收盘，长城汽车上涨空间最大，为95.82%。文章来源：东方财富研究中心","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072920101194c18092&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072920101194c18092&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","02359","603486","GWLLF","600483","82333","02333","601633","GWLLY","603259","600276","605499"],"gpt_icon":0},{"id":"2555405679","title":"镁伽科技冲刺IPO！高盛、中金、药明康德押注的百亿龙头，3年巨亏22亿！","url":"https://stock-news.laohu8.com/highlight/detail?id=2555405679","media":"智药局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555405679?lang=zh_cn&edition=full","pubTime":"2025-07-29 19:06","pubTimestamp":1753787212,"startTime":"0","endTime":"0","summary":"镁伽科技称2023年这部分的收入减少主要由于部分疫情相关产品的市场需求减少。在新能源、半导体等领域的推动下，镁伽科技智能制造业务收入快速增长，从2022年的2.68亿元跃升至2024年的6.34亿元。大额亏损使得镁伽科技的现金流状况同样不容乐观。除了现金流的压力，镁伽科技的债务状况也在持续恶化。或许这也是镁伽科技冲刺港股IPO的原因之一，通过上市融资，来缓解当下的燃眉之急。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729200801a469a631&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729200801a469a631&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002270589.USD","LU2237443622.USD","LU0251142724.SGD","LU1894683264.USD","LU1894683348.USD","LU2471134796.USD","603259","IE00BFXG1179.USD","LU2471134523.USD","IE00B19Z3B42.SGD","IE0034235188.USD","LU2750360641.GBP","LU2237443465.HKD","BK4550","LU1868836757.USD","BK4504","LU0742534661.SGD","BK4127","LU0048573561.USD","LU0096364046.USD","IE00B19Z3581.USD","IE0004091025.USD","GS","LU1791807156.HKD","LU1668664300.SGD","LU2237443382.USD","BK4552","BK4588","IE0004086264.USD","LU2471134879.HKD","BK4533","LU1868837136.USD","LU0106831901.USD","IE00BSNM7G36.USD","LU2750360997.AUD","BK4585","LU2237443895.HKD","LU1868837300.USD","LU2471134952.CNY","02359","LU2237438978.USD","LU2237443978.SGD","LU0251131958.USD","LU1868836914.USD","LU2237443549.SGD","LU1868836591.USD","BK4516","LU0061475181.USD"],"gpt_icon":0},{"id":"2555034085","title":"7月29日上证50_上涨0.37%，板块个股药明康德、寒武纪U涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2555034085","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555034085?lang=zh_cn&edition=full","pubTime":"2025-07-29 17:55","pubTimestamp":1753782935,"startTime":"0","endTime":"0","summary":"7月29日，截至收盘，上证50_概念上涨0.37%，板块资金流出161062.40万。上涨个股家数21个，下跌个股家数29个。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/29175552057124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0052750758.USD","LU0456842615.SGD","BK0216","LU1046422090.SGD","BK1141","SG9999001051.SGD","LU1997245177.USD","LU1934453819.USD","LU2488822045.USD","SG9999001069.SGD","SG9999002950.SGD","SGXZ81163826.USD","SG9999001093.SGD","SGXZ49509284.SGD","LU0320764599.SGD","688256","LU1969619763.USD","LU2495084118.USD","LU0708995583.HKD","LU2045819591.USD","02359","LU2328871848.SGD","SG9999003461.SGD","LU1979443071.USD","LU1997244956.HKD","BK1583","000001.SH","BK1576","BK0231","SG9999006597.SGD","LU2125910500.SGD","SGXZ90724238.SGD","603259","LU1997245094.SGD","LU2242644610.SGD"],"gpt_icon":1},{"id":"2555031946","title":"药明康德(02359.HK)：股份回购价格上限调整为114.15 元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2555031946","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555031946?lang=zh_cn&edition=full","pubTime":"2025-07-29 17:28","pubTimestamp":1753781287,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1046422090.SGD","BK1583","LU1934453819.USD","LU2125910500.SGD","LU1997245094.SGD","CNHmain","603259","UCmain","LU1979443071.USD","LU2242644610.SGD","BK0216","LU1969619763.USD","LU0456842615.SGD","LU1997245177.USD","02359","LU0320764599.SGD","LU1997244956.HKD","399300","LU2045819591.USD","LU2328871848.SGD","CYB","LU2488822045.USD","BK1141","MUCmain","MCNHmain","LU2495084118.USD","LU0052750758.USD","BK1576","159982","LU0708995583.HKD"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753902925931,"stockEarnings":[{"period":"1week","weight":0.1759},{"period":"1month","weight":0.4213},{"period":"3month","weight":0.7069},{"period":"6month","weight":0.8243},{"period":"1year","weight":1.482},{"period":"ytd","weight":0.8349}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":0.0497},{"period":"3month","weight":0.1027},{"period":"6month","weight":0.1123},{"period":"1year","weight":0.2558},{"period":"ytd","weight":0.0788}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"无锡药明康德新药开发股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"235455人(较上一季度减少3.27%)","perCapita":"10554股","listingDate":"2018-05-08","address":"江苏省无锡市滨湖区马山五号桥","registeredCapital":"287221万元","survey":"　　无锡药明康德新药开发股份有限公司的主营业务是为全球医药及生命科学行业提供一体化、端到端的新药研发和生产服务。公司的主要产品是化学业务、测试业务、生物学业务。","listedPrice":21.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,603259,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}